Rocket Lab's Order Book Tops 100 Missions as ARK and Citi Both Step Up

ARK Invest bought 233,482 Rocket Lab shares and Citigroup began coverage with a Buy rating and $105 target, as the Synspective deal lifted backlog past 100 launches.

Fresh institutional money is flowing into Rocket Lab. ARK Invest picked up 233,482 shares on Thursday through several of its exchange-traded funds, a move that helped lift the stock on Friday. The same day, Citigroup kicked off coverage of the launch company with a Buy rating and a $105 price target — a twin endorsement that landed just as Rocket Lab's commercial pipeline hit a new milestone.

That milestone is the multi-year agreement with Synspective, the largest single commercial contract ever signed for the Electron rocket. The deal covers 20 dedicated launches running from 2028 through 2031, with the remaining terms left undisclosed. Stacked on top of earlier bookings, Synspective now accounts for 47 committed missions, pushing Rocket Lab's total backlog beyond 100 launches.

A Backlog Built on Repeat Business

The value of the Synspective contract lies less in its headline size than in what it says about customer retention. Satellite operators rarely hand out multi-year launch commitments unless the rocket has proven it can fly on schedule, and Rocket Lab's recent record supports that case. On September 26, an Electron lifted off from New Zealand and placed the 13th StriX satellite into low Earth orbit without incident.

Secured utilization through 2031 gives management a rare luxury in a capital-hungry industry: visibility. With years of launches locked in, the company can spread fixed operating costs across a predictable cadence and push toward scale efficiencies that pure backlog announcements cannot deliver.

Iridium Shareholders Give a Near-Unanimous Nod

Away from the launch pad, Rocket Lab's biggest strategic test is already underway. Roughly a week ago, Iridium Communications shareholders voted on the proposed takeover, with about 99.6% of votes cast in favor — a decisive mandate. The stock has added 1.2% since that ballot.

If completed, the transaction would transform Rocket Lab from a company that ferries other operators' payloads into orbit into one that runs its own global communications network. The shift promises recurring cash flows, but it also raises the operational stakes: absorbing an established satellite operator will consume substantial financial and human resources. Regulatory approvals and other closing conditions still stand in the way.

Insider Selling Draws a Passing Glance

Not every signal this week pointed upward. CFO Adam Spice sold 140,157 shares on Thursday, according to a regulatory filing. The disposal was executed under a pre-arranged 10b5-1 trading plan, a structure that typically governs sales scheduled well in advance for portfolio diversification rather than reflecting a view on the business. Even so, insider sales after a rally tend to leave cautious investors uneasy.

Where the Stock Stands

Rocket Lab shares changed hands at EUR 65.70, up 4.6% on Friday. Over the past 30 days the stock has climbed 19%, yet it remains 51% below its 52-week high — a gap that captures both how far the shares had fallen and how much skepticism has yet to unwind. Citigroup's $105 target implies the bank sees considerably more room from here.

The company is also pointing to technologies designed to reach beyond low Earth orbit, supporting future missions to the Moon and Mars. Those ambitions carry real risk of overextension, which makes the stability of the core launch business the anchor for everything else. For investors watching the name, the coming months will hinge less on day-to-day price swings than on how cleanly management integrates Iridium and keeps the Electron flying on time.